Azenta Q2 2024 Adj EPS $0.05 Beats $0.02 Estimate, Sales $159.134M Miss $159.887M Estimate

5/8/24 4:35:07 PM ET

Industrial Machinery/Components

Technology

Get the next $AZTA alert in real time by email

Azenta (NASDAQ:AZTA) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.02 by 150 percent. The company reported quarterly sales of $159.134 million which missed the analyst consensus estimate of $159.887 million by 0.47 percent. This is a 7.23 percent increase over sales of $148.401 million the same period last year.

Get the next $AZTA alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$AZTA

Date	Price Target	Rating	Analyst
4/4/2024	$64.00	Hold	Jefferies
2/1/2024	$61.00 → $79.00	Buy	B. Riley Securities
7/19/2023		Mkt Perform	Raymond James
5/10/2023		Overweight → Sector Weight	KeyBanc Capital Markets
2/9/2023	$65.00 → $60.00	Overweight → Equal-Weight	Stephens
1/3/2023	$60.00 → $62.00	Outperform → In-line	Evercore ISI
3/31/2022	$106.00	Buy	B. Riley Securities
3/21/2022	$100.00	Outperform	Evercore ISI

More analyst ratings

$AZTA
Press Releases

Fastest customizable press release news feed in the world

Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin
11/19/24 5:56:00 PM ET
$AZTA
$CON
$ENV
$FLEX
Industrial Machinery/Components
Technology
Medical Specialities
Health Care
Azenta to Participate in Stephens Annual Investment Conference
BURLINGTON, Mass., Nov. 14, 2024 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that Company management will participate in Stephens Annual Investment Conference, on Wednesday November 20, 2024, which includes a presentation beginning at 1:00 pm CT. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event. About Azenta Life Sciences Azenta, Inc. (NASDAQ:AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutio
11/14/24 8:00:00 AM ET
$AZTA
Industrial Machinery/Components
Technology
Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO
FY'24 revenue growth of 4%, reported and organic, in combined Sample Management Solutions and MultiomicsFY'25 organic revenue growth expected to be 3% to 5% year over year, with Adjusted EBITDA margin expansion of approximately 300 basis pointsPursuing a sale of B Medical Systems to simplify portfolio and drive revenue growth and profitabilityAnnounces appointment of Lawrence Y. Lin as Chief Financial Officer; Herman Cueto to remain as advisor to ensure smooth transitionBURLINGTON, Mass., Nov. 12, 2024 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today reported financial results for the fourth quarter and fiscal year ended September 30, 2024. Fiscal Year 2024 Highlights: Q4'24 revenue growth o
11/12/24 4:05:00 PM ET
$AZTA
Industrial Machinery/Components
Technology

$AZTA
Leadership Updates

Live Leadership Updates

Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin
11/19/24 5:56:00 PM ET
$AZTA
$CON
$ENV
$FLEX
Industrial Machinery/Components
Technology
Medical Specialities
Health Care
Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value
William L. Cornog, Quentin Koffey and Alan J. Malus Add Deep Industry Expertise and Track Records of Shareholder Value Creation to the Board Establishes Value Creation Committee of the Board Comprised of New Directors, CEO John Marotta, and Current Director Martin Madaus Reaffirms Full-Year 2024 Financial Guidance BURLINGTON, Mass., Nov. 4, 2024 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) ("Azenta" or "the Company"), today announced the appointment of three new independent directors to its Board. William Cornog, former head of KKR Capstone, the portfolio operations team of KKR & Co., and Alan Malus, former Corporate Executive Vice President of Thermo Fisher, join as part of Azenta's ongoing i
11/4/24 8:00:00 AM ET
$AZTA
$BV
$LVWR
Industrial Machinery/Components
Technology
Business Services
Consumer Discretionary
AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO
Succeeds Dr. Stephen Schwartz Following 14-Year Tenure BURLINGTON, Mass., Sept. 4, 2024 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) ("Azenta" or "the Company"), today announced that John P. Marotta will join the Company as President and CEO effective September 9, 2024, succeeding Dr. Stephen Schwartz, who is retiring following a distinguished tenure. Dr. Schwartz will remain as an advisor to Azenta to ensure a smooth and successful transition. Mr. Marotta has two decades of experience leading global companies in life sciences, medical devices, and diagnostics, and is joining Azenta from Patient Square Capital, a leading healthcare investment firm, where he serves as Executive in Residence. P
9/4/24 8:00:00 AM ET
$AZTA
Industrial Machinery/Components
Technology

$AZTA
Financials

Live finance-specific insights

Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO
FY'24 revenue growth of 4%, reported and organic, in combined Sample Management Solutions and MultiomicsFY'25 organic revenue growth expected to be 3% to 5% year over year, with Adjusted EBITDA margin expansion of approximately 300 basis pointsPursuing a sale of B Medical Systems to simplify portfolio and drive revenue growth and profitabilityAnnounces appointment of Lawrence Y. Lin as Chief Financial Officer; Herman Cueto to remain as advisor to ensure smooth transitionBURLINGTON, Mass., Nov. 12, 2024 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today reported financial results for the fourth quarter and fiscal year ended September 30, 2024. Fiscal Year 2024 Highlights: Q4'24 revenue growth o
11/12/24 4:05:00 PM ET
$AZTA
Industrial Machinery/Components
Technology
Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast
BURLINGTON, Mass., Nov. 4, 2024 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) will announce fiscal fourth quarter and full year 2024 earnings which ended on September 30, 2024, on Tuesday, November 12, 2024, after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Tuesday, November 12, 2024, at 4:30 p.m. Eastern Time. Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events. A replay will be available beginning at 8:30 a.m. ET on November 13, 2024. About Azenta Life Sciences Azenta, Inc. (NASDAQ:AZTA) is a leading provider of life sciences solu
11/4/24 4:05:00 PM ET
$AZTA
Industrial Machinery/Components
Technology
Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024
BURLINGTON, Mass., Aug. 6, 2024 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today reported financial results for the third quarter ended June 30, 2024. Quarter Ended Dollars in millions, except per share data June 30, March 31, June 30, Change 2024 2024 2023 Prior Qtr Prior Yr. Revenue from Continuing Operations $ 173 $ 159 $ 166 9 % 4 % Organic growth 5 % Sample Management Solutions $ 81 $ 74 $ 75 9 % 7 % Multiomics $ 64 $ 62 $ 64 2 % (0) % B Medical Systems $ 29 $ 23 $ 27 25 % 7 % Diluted EPS Continuing Operations $ (0.12) $ (2.47) $ (0.04) 95 % nm Diluted EPS Total $ (0.12) $ (2.47) $ (0.02) 95 % nm Non-GAAP Diluted EPS Continuing Operations $ 0.16 $ 0.05 $ 0.13 nm 25 % Adjusted EBITDA - C
8/6/24 4:05:00 PM ET
$AZTA
Industrial Machinery/Components
Technology

Azenta Q2 2024 Adj EPS $0.05 Beats $0.02 Estimate, Sales $159.134M Miss $159.887M Estimate

Chat with this insight

Recent Analyst Ratings for $AZTA

$AZTA Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

President and CEO Marotta John was granted 83,622 units of Common and bought $552,904 worth of Common (13,967 units at $39.59), increasing direct ownership by 2,982% to 100,862 units (SEC Form 4)

Director Cornog William L bought $495,000 worth of Common (12,500 units at $39.60) (SEC Form 4)

Director Hirsch Didier bought $39,500 worth of Common (1,000 units at $39.50), increasing direct ownership by 41% to 3,465 units (SEC Form 4)

$AZTA Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SVP and CHRO Pirogova Olga sold $21,958 worth of Common (548 units at $40.07), decreasing direct ownership by 3% to 19,373 units (SEC Form 4)

SVP, General Counsel, Secy. Joseph Jason sold $45,640 worth of Common (1,139 units at $40.07), decreasing direct ownership by 1% to 112,564 units (SEC Form 4)

SVP and General Manager, Genom Zhou Ginger sold $19,674 worth of Common (491 units at $40.07), decreasing direct ownership by 2% to 27,499 units (SEC Form 4)

$AZTA SEC Filings

Azenta Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

Azenta Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

Azenta Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

$AZTA Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Jefferies initiated coverage on Azenta with a new price target

B. Riley Securities reiterated coverage on Azenta with a new price target

Raymond James initiated coverage on Azenta

$AZTA Press Releases

Fastest customizable press release news feed in the world

Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

Azenta to Participate in Stephens Annual Investment Conference

Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO

$AZTA Leadership Updates

Live Leadership Updates

Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value

AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO

$AZTA Financials

Live finance-specific insights

Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO

Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast

Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024

$AZTA Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Azenta Inc.

Amendment: SEC Form SC 13D/A filed by Azenta Inc.

SEC Form SC 13G filed by Azenta Inc.

$AZTA Market Insights

Live Market Insights

Azenta To Provide Proteomics Technology For FinnGen Project, Profiling Up To 20,000 Individuals; Project Analyzes Genomic And Health Data From 500,000 Finnish Biobank Participants

Decoding 5 Analyst Evaluations For Azenta

Evercore ISI Group Maintains In-Line on Azenta, Raises Price Target to $53

Recent Analyst Ratings for
$AZTA

$AZTA
Insider Purchases

$AZTA
Insider Trading

$AZTA
SEC Filings

$AZTA
Analyst Ratings

$AZTA
Press Releases

$AZTA
Leadership Updates

$AZTA
Financials

$AZTA
Large Ownership Changes

$AZTA
Market Insights